Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als crawled time : 15:00 save search
Coya Therapeutics Presents New Experimental Data Supporting the Mechanism of Action of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) at the 22nd Annual Northeast ALS (NEALS) Consortium Meeting
Published: 2023-10-05 (Crawled : 15:00) - biospace.com/
COYA | $7.87 -6.75% -7.24% 54K
|
|
| O: 0.0%
H: 13.48%
C: 2.42%
als sclerosis treatment meeting therapeutics
RELYVRIO® and AMX0114 Data to be Presented at 22nd Annual Northeast ALS Consortium (NEALS) Meeting
Published: 2023-10-02 (Crawled : 15:00) - biospace.com/
AMLX A | $1.88 -5.05% -5.32% 2.5M
|
|
| O: -0.05%
H: 0.55%
C: -0.98%
amx0114 relyvrio als meeting
BrainStorm Touts Biomarker Data for ALS Candidate After Two FDA Rebuffs
Published: 2023-07-10 (Crawled : 15:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
fda candidate als biomarker
Amylyx Pharmaceuticals Announces Completion of Enrollment in Global Phase 3 PHOENIX Trial of AMX0035 in ALS
Published: 2023-02-02 (Crawled : 15:00) - biospace.com/
AMLX A | $1.88 -5.05% -5.32% 2.5M
|
|
| O: -0.2%
H: 3.98%
C: -5.88%
amx0035 pharmaceuticals global als trial
NeuroSense Receives Regulatory Approval to Commence Patient Enrollment in Italy for its Phase 2b Trial in ALS
Published: 2022-11-16 (Crawled : 15:00) - prnewswire.com
NRSN | $1.435 -5.59% -5.92% 120K
|
|
| O: -5.29%
H: 24.22%
C: 11.84%
als trial approval phase 2b
Seelos Therapeutics to Collaborate with the Healey & AMG Center for ALS in an Expanded Access Program
Published: 2022-09-30 (Crawled : 15:00) - biospace.com/
SEEL | $0.3502 3.61% 3.48% 290K
|
Health Technology
|
| O: -0.93%
H: 7.55%
C: -2.83%
als program therapeutics
Denali/Sanofi ALS Candidate Hits Phase II as Awareness Month Begins
Published: 2022-05-03 (Crawled : 15:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
als
New Analysis from Global Industry Analysts Reveals Steady Growth for Battery Management ICs, with the Market to Reach $8.9 Billion Worldwide by 2026
Published: 2022-03-21 (Crawled : 15:00) - prnewswire.com
STMEF | $40.836 -5.77% 2K
|
Electronic Technology
|
| O: -0.38%
H: 0.0%
C: -1.86%
ROHCY | $14.06 2.58% 38K
|
Manufacturing
|
| O: -0.33%
H: 0.72%
C: 0.72%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -2.14%
H: 0.0%
C: 0.0%
STM | $38.6 -2.55% 0.0% 4M
|
Electronic Technology
|
| O: -0.07%
H: 0.37%
C: 0.0%
TXN | $159.6 -2.49% -2.55% 10M
|
Electronic Technology
|
| O: -0.45%
H: 1.07%
C: 0.65%
SWKS 4 | $96.09 -1.57% -1.59% 2.6M
|
Electronic Technology
|
| O: -0.38%
H: 1.06%
C: -0.1%
SMTC | $31.05 -3.12% -3.22% 2.7M
|
Electronic Technology
|
| O: 0.0%
H: 1.25%
C: -0.31%
NXPI | $215.2 -1.89% -1.93% 2.7M
|
Electronic Technology
|
| O: -0.81%
H: 1.24%
C: -0.19%
ADI | $183.31 -2.28% -2.33% 4.1M
|
Electronic Technology
|
| O: -1.01%
H: 1.82%
C: 1.5%
battery als growth
New Analysis from Global Industry Analysts Reveals Steady Growth for Industrial Gearbox, with the Market to Reach $49.2 Billion Worldwide by 2026
Published: 2022-03-21 (Crawled : 15:00) - prnewswire.com
EMR | $108.58 -0.67% 0.0% 2.1M
|
Producer Manufacturing
|
| O: 0.87%
H: 1.1%
C: 0.37%
als trial growth
3/16/22 – RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
Published: 2022-03-16 (Crawled : 15:00) - respirerx.com
RSPI | $0.0008 0.0% 600K
|
Manufacturing
|
| O: 69.0%
H: 0.0%
C: -32.54%
als
Biomaterials Market Size to Reach USD 2,12,405.2 Million by 2030 at CAGR 12.7% - Valuates Reports
Published: 2022-03-16 (Crawled : 15:00) - prnewswire.com
ZBH | $119.43 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.67%
H: 1.92%
C: 1.66%
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: 0.0%
CRS | $78.04 -1.69% 0.0% 680K
|
Non-Energy Minerals
|
| O: 0.43%
H: 3.69%
C: -0.59%
als 2 million report
REFINITIV LIPPER NAMES T. ROWE PRICE 2022 BEST OVERALL LARGE U.S. FUND MANAGEMENT GROUP; FIRM ALSO RECEIVES 24 AWARDS FOR FUND PERFORMANCE
Published: 2022-03-16 (Crawled : 15:00) - prnewswire.com
TROW | $108.73 0.01% 0.01% 1.7M
|
Finance
|
| O: 1.79%
H: 3.53%
C: 2.3%
als fun awards rice perform group
I&M Seeks Detailed Proposals for 1,300 MW of Solar, Wind Energy
Published: 2022-03-15 (Crawled : 15:00) - prnewswire.com
AEP | $84.23 2.02% 1.98% 5.4M
|
Utilities
|
| O: 0.84%
H: 0.65%
C: 0.6%
solar als pos energy
3 patient referrals process pain points—and how to solve them
Published: 2022-03-14 (Crawled : 15:00) - phreesia.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -12.53%
H: 0.0%
C: 0.0%
als
CMC Materials Announces Stockholder Approval of Merger Agreement with Entegris
Published: 2022-03-03 (Crawled : 15:00) - globenewswire.com
ENTG | $122.19 -3.86% -4.01% 1.7M
|
Electronic Technology
|
| O: 1.11%
H: 0.03%
C: -3.63%
CCMP | $173.69 0.59% 0.0%
|
Electronic Technology
|
| O: 0.5%
H: 0.0%
C: -1.44%
als approval merger agreement merge
Ampio Pharmaceuticals, Inc. to Host a Conference Call and Webinar
Published: 2022-03-02 (Crawled : 15:00) - biospace.com/
AMPE | $0.242 0.0% 15K
|
Health Technology
|
| O: 2.88%
H: 0.0%
C: 0.0%
als conference
NeuroSense Therapeutics Granted Key Patent for its ALS Drug PrimeC in Australia
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
NRSN | $1.435 -5.59% -5.92% 120K
|
|
| O: 0.38%
H: 9.96%
C: -18.39%
als drug patent granted therapeutics australia grant primec
Tonix Pharmaceuticals Announces Research Agreement with the French National Institute of Health and Medical Research (Inserm) to Study the Mechanism of Oxytocin-Mediated Improvement of Eating Behaviors in Prader-Willi Mice
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 1.2%
H: 6.32%
C: 4.4%
health als research media oxytocin ism
Pause of GSK's RSV Vaccine Trials in Pregnant Women Deepens
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
als trials trial women vaccine
Research Roundup: Neurons Key to Parkinson's ID’ed, New ALS Mechanism Discovered
Published: 2022-02-25 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
als parkinson research ism
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.